Cambridge Institute for Medical Research and Department of Clinical Biochemistry, Addenbrooke's Hospital, Cambridge, UK.
Physiol Behav. 2012 Jun 6;106(3):387-93. doi: 10.1016/j.physbeh.2011.12.001. Epub 2011 Dec 13.
The hormones glucagon-like peptide-1 (GLP-1) and glucose-dependent insulintropic polypeptide (GIP) are secreted after a meal. Like other enteroendocrine hormones they help to orchestrate the bodies' response to the availability of newly absorbable nutrients and are noteworthy as they stimulate postprandial insulin secretion, underlying what is known as the incretin effect. GLP-1-mimetics are now widely used in the treatment of type 2 diabetes and advantages over older insulinotropic therapies include weight loss. An alternative treatment regime might be the recruitment of endogenous GLP-1, however, very little is known about the physiological control of enteroendocrine responses. This review focuses on the molecular mechanisms to detect nutrient arrival in the gut that have been implicated within the incretin secreting cells.
激素胰高血糖素样肽-1 (GLP-1) 和葡萄糖依赖性胰岛素促分泌多肽 (GIP) 在进食后分泌。像其他肠内分泌激素一样,它们有助于协调身体对新吸收的营养物质的反应,并且值得注意的是,它们刺激餐后胰岛素分泌,这就是所谓的肠促胰岛素效应。GLP-1 类似物现在广泛用于治疗 2 型糖尿病,与较旧的胰岛素促分泌治疗相比,其优点包括体重减轻。另一种治疗方案可能是招募内源性 GLP-1,但是,对于肠内分泌反应的生理控制知之甚少。这篇综述重点介绍了在肠促胰岛素分泌细胞中涉及的检测肠道中营养物质到达的分子机制。